Alkaptonuria is a rare condition in which a person's urine turns a dark brownish-black color when exposed to air. Alkaptonuria is part of a group of conditions known as an inborn error of metabolism.
AKU; Alcaptonuria; Homogentisic acid oxidase deficiency; Alcaptonuric ochronosis
A defect in the HGD gene causes alkaptonuria.
The gene defect makes the body unable to properly break down certain amino acids (tyrosine and phenylalanine). As a result, a substance called homogentisic acid builds up in the skin and other body tissues. The acid leaves the body through the urine. The urine turns brownish-black when it mixes with air.
Alkaptonuria is inherited, which means it is passed down through families. If both parents carry a nonworking copy of the gene related to this condition, each of their children has a 25% (1 in 4) chance of developing the disease.
Urine in an infant's diaper may darken and can turn almost black after several hours. However, many people with this condition may not know they have it until mid-adulthood (around age 40), when joint and other problems occur.
Symptoms may include:
Exams and Tests
A urine test is done to test for alkaptonuria. If ferric chloride is added to the urine, it will turn the urine black in people with this condition.
Some people benefit from high-dose vitamin C. This has been shown to decrease the buildup of brown pigment in the cartilage and may slow the development of arthritis.
The outcome is expected to be good.
People with this condition also can get arthritis in adulthood. The build-up of homogentisic acid in the cartilage causes arthritis in about half of older adults with alkaptonuria.
When to Contact a Medical Professional
Call your health care provider if you notice that your own urine or your child's urine becomes dark brown or black when it is exposed to air.
Genetic counseling is recommended for people with a family history of alkoptonuria who are considering having children.
A blood test can be done to see if you carry the gene for alkaptonuria.
Prenatal tests (amniocentesis or chorionic villus sampling) can be done to screen a developing baby for this condition if the genetic change has been identified.
Chakrapani A, Gissen P, McKiernan P. Disorders of tyrosine metabolism. In: Saudubray J-M, van den Berghe G, Walter JH, eds. Inborn Metabolic Diseases: Diagnosis and Treatment. 5th ed. New York, NY: Springer; 2012:chap 18.
Rezvani I, Melvin JJ. Defects in Metabolism of Amino Acids. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, PA: Elsevier Saunders; 2011:chap 79.
Review Date: 4/20/2015
Reviewed By: Chad Haldeman-Englert, MD, FACMG, Wake Forest School of Medicine, Department of Pediatrics, Section on Medical Genetics, Winston-Salem, NC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.